https://flare.lucidgraphics.co.uk/flare-therapeutics-launches-with-82-million-series-a-financing-to-advance-precision-oncology-pipeline-based-on-novel-drug-discovery-approach-for-transcription-factors/ 2021-05-13T11:11:04+00:00 https://flare.lucidgraphics.co.uk/429-2/ 2021-10-25T12:00:09+00:00 https://flare.lucidgraphics.co.uk/a-jubb-cmo/ 2022-04-26T12:13:17+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-appoints-amit-rakhit-m-d-as-president-and-chief-executive-officer/ 2022-07-25T12:03:33+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-presents-preclinical-data-that-show-potential-of-novel-pparg-inhibitors-to-treat-urothelial-cancer-at-2022-eortc-nci-aacr-symposium/ 2022-10-26T11:26:36+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-presents-comprehensive-real-world-data-in-advanced-and-metastatic-urothelial-cancer-in-support-of-therapeutic-targeting-of-pparg-at-2022-eortc-nci-aacr-symposium/ 2022-10-28T11:32:02+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-at-piper-sandler-34th-annual-healthcare-conference/ 2023-02-21T15:25:33+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-at-guggenheim-healthcare-talks-oncology-day/ 2023-02-21T15:26:04+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-overview-of-clinical-candidate-fx-909-at-aacr-annual-meeting/ 2023-03-14T20:42:04+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-announces-oversubscribed-123-million-series-b-financing/ 2023-03-22T11:20:28+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-further-strengthens-leadership-team-with-key-executive-appointments-and-promotions/ 2023-03-30T17:07:07+00:00 https://flare.lucidgraphics.co.uk/caris-life-sciences-and-flare-therapeutics-announce-strategic-preferred-portfolio-partnership-to-advance-flares-precision-oncology-pipeline/ 2023-04-18T14:08:07+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-presents-first-preclinical-data-on-lead-asset-fx-909-a-novel-small-molecule-pparg-inhibitor-to-potentially-treat-urothelial-cancer-at-the-2023-aacr-annual-meeting/ 2023-04-18T14:32:11+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-named-to-inc-magazines-annual-list-of-best-workplaces-for-2023/ 2023-05-09T12:58:01+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-biomarker-data-for-clinical-candidate-fx-909-at-2023-aacr-nci-eortc-international-conference/ 2023-10-04T17:59:27+00:00 https://flare.lucidgraphics.co.uk/761-2/ 2023-10-13T19:02:24+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-announces-first-patients-dosed-in-first-in-human-phase-1-clinical-study-of-fx-909-in-advanced-solid-malignancies-including-urothelial-cancer/ 2023-10-19T12:35:28+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-new-translational-data-in-support-of-clinical-candidate-fx-909s-phase-1-development-at-sitc-2023-annual-meeting/ 2023-10-31T13:03:26+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-presents-new-translational-data-in-support-of-lead-asset-fx-909-for-the-treatment-of-muscle-invasive-urothelial-cancer-at-sitc-2023-annual-meeting/ 2023-11-03T16:10:26+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-presents-fx-909-phase-1-dose-escalation-and-expansion-clinical-trial-design-at-the-2024-asco-genitourinary-cancers-symposium/ 2024-01-26T12:00:06+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-immune-profiling-data-from-urothelial-cancer-patients-treated-with-anti-pd1-therapy-at-aacr-2024-annual-meeting/ 2024-03-06T01:37:39+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-data-characterizing-pparg-expression-patterns-in-urothelial-cancer-patient-immune-cell-subsets-after-anti-pd1-therapy/ 2024-04-09T21:08:53+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-appoints-douglas-manion-m-d-frcp-c-as-chief-executive-officer/ 2024-04-23T11:39:10+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-at-goldman-sachs-45th-annual-global-healthcare-conference/ 2024-06-03T12:00:17+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-at-two-upcoming-november-conferences/ 2024-11-06T15:43:54+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-announces-strategic-discovery-collaboration-with-roche-to-address-previously-undrugged-transcription-factor-targets-in-oncology/ 2024-11-12T11:56:53+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-at-two-upcoming-december-conferences/ 2024-11-25T13:00:43+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-participate-in-jefferies-global-healthcare-conference/ 2025-06-18T15:07:27+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-announces-initiation-of-phase-1b-study-of-fx-909-for-treatment-of-metastatic-urothelial-cancer/ 2025-08-05T13:30:47+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-participate-in-upcoming-investor-conferences-in-september/ 2025-09-05T13:52:27+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-fx-909-phase-1a-data-in-oral-presentation-at-upcoming-aacr-nci-eortc-international-conference/ 2025-10-14T12:29:47+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-announces-clinical-trial-collaboration-and-supply-agreement-with-merck-to-evaluate-fx-909-in-combination-with-keytruda-pembrolizumab-in-new-cohort-of-ongoing-phase-1-trial-i/ 2025-10-21T11:03:04+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-presents-part-a-data-from-fx-909-phase-1-study-at-aacr-nci-eortc-international-conference/ 2025-10-24T16:40:06+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-correlative-biomarker-analysis-from-the-fx-909-phase-1a-clinical-study-at-upcoming-sitc-2025-40th-anniversary-annual-meeting/ 2025-10-30T13:00:55+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-presents-correlative-biomarker-analysis-from-the-fx-909-phase-1a-clinical-study-at-sitc-2025-40th-anniversary-annual-meeting/ 2026-02-12T01:25:40+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-participate-in-upcoming-investor-conferences-in-november/ 2026-02-12T01:25:47+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-appoints-stephen-l-eck-m-d-ph-d-as-chief-medical-officer/ 2026-02-12T01:52:19+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-present-at-44th-annual-j-p-morgan-healthcare-conference/ 2026-02-12T01:52:30+00:00 https://flare.lucidgraphics.co.uk/flare-therapeutics-to-participate-in-piper-sandler-37th-annual-healthcare-conference/ 2026-02-12T01:52:36+00:00